Research & Development
21 September 2026 - Biopharmaceutical company Insmed Incorporated (Nasdaq: INSM) disclosed on Monday that the US Food and Drug Administration has accepted its supplemental New Drug Application for ARI...
21 September 2026 - Biopharmaceutical company Precigen Inc (Nasdaq: PGEN) disclosed on Monday that it has received US Food and Drug Administration platform technology designation for its AdenoVerse im...
21 September 2026 - British-Swedish biopharmaceutical company AstraZeneca plc (STO:AZN) (LON:AZN) (NYSE:AZN) and Japanese healthcare company Daiichi Sankyo Co Ltd (TYO:4568) announced on Monday that E...
21 September 2026 - Biotherapeutics company PureTech Health plc (LSE: PRTC) announced on Monday that it has completed a successful End-of-Phase 1 meeting with the U.S. Food and Drug Administration and...
21 September 2026 - Danish biotechnology company Zealand Pharma A/S (Nasdaq: ZEAL) announced on Friday that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (...
18 September 2026 - Clinical-stage biotechnology company MaaT Pharma (Euronext Paris:MAAT) confirmed on Friday that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines ...